Cited by 114Growth Hormone and Insulin-like Growth FactorsHormonal and reproductive studiesMenopause: Health Impacts and Treatments

Oral estrogen antagonizes the metabolic actions of growth hormone in growth hormone-deficient women

Wolthers, Troels, Hoffman, David M., Nugent, Ailish G., Duncan, Mark W, Umpleby, Margot, Ho, Ken K. Y.·2001·American Journal of Physiology-Endocrinology and Metabolism

Abstract

We have determined whether oral estrogen reduces the biological effects of growth hormone (GH) in GH-deficient (GHD) women compared with transdermal estrogen treatment. In two separate studies, eight GHD women randomly received either oral or transdermal estrogen for 8 wk before crossing over to the alternate route of administration. The first study assessed the effects of incremental doses of GH (0.5, 1.0, 2.0 IU/day for 1 wk each) on insulin-like growth factor I (IGF-I) levels during each estrogen treatment phase. The second study assessed the effects of GH (2 IU/day) on lipid oxidation and on protein metabolism using the whole body leucine turnover technique. Mean IGF-I level was significantly lower during oral estrogen treatment (P < 0.05) and rose dose dependently during GH administration by a lesser magnitude (P < 0.05) compared with transdermal treatment. Postprandial lipid oxidation was significantly lower with oral estrogen treatment, both before (P < 0.05) and during (P < 0.05) GH administration, compared with transdermal treatment. Protein synthesis was lower during oral estrogen both before and during GH administration (P < 0.05). Oral estrogen antagonizes several of the metabolic actions of GH. It may aggravate body composition abnormalities already present in GHD women and attenuate the beneficial effects of GH therapy. Estrogen replacement in GHD women should be administered by a nonoral route.

Integrity signals

Registry

Crossref · 10.1152/ajpendo.2001.281.6.e1191

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wolthers, T., Hoffman, D. M., Nugent, A. G., Duncan, M. W., Umpleby, M., & Ho, K. K. Y.
Affiliations
  • Garvan Institute of Medical Research (AU)
  • St Thomas' Hospital (GB)
  • Endocrine and Diabetic Unit, St. Thomas's Hospital, London SE1 7EH, United Kingdom
Venue
American Journal of Physiology-Endocrinology and Metabolism
Published
2001-12-01
Volume
281
Issue
6
Pages
E1191-E1196
ISSN
  • 0193-1849 (ISSN-L)
  • 1522-1555
OpenAlex
W2113298229
Cited by
114
References
38
Citations by year
2026: 1 · 2025: 1 · 2024: 4 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 1 · 2019: 3 · 2018: 3 · 2017: 5 · 2016: 4 · 2015: 3 · 2014: 3 · 2013: 5 · 2012: 4
FWCI
4.14
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Physiology-Endocrinology and Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • Open Research (University of Surrey) (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords
oral estrogen, transdermal estrogen, growth hormone deficiency, growth hormone therapy, insulin-like growth factor I, protein synthesis, leucine turnover, body composition, women
MeSH terms
Administration, Cutaneous, Administration, Oral, Adult, Dose-Response Relationship, Drug, Double-Blind Method, Estradiol, Estrogens, Female, Humans, Hypopituitarism, Insulin-Like Growth Factor I, Leucine, Medroxyprogesterone, Middle Aged, Proteins, Growth Hormone, Cross-Over Studies, Human Growth Hormone, Progesterone Congeners, Lipid Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review